EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Controlling Imipenem-Resistant Pseudomonas aeruginosa in Hospitals: Effect of Improved Infection Control Measures from an Interrupted Time-Series Study

Chandra Kanta Bhusal, Hanaa Jabbar Rasheed

World Journal of Experimental Biosciences · 09.04.2026 · 10-15

DOI: 10.65329/wjeb.v14.01.03 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Experimental Biosciences, online erschienen am 09.04.2026. Verfasst von Chandra Kanta Bhusal und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imipenem-resistant Pseudomonas aeruginosa (IRPA) causes serious healthcare-associated infections and negatively affects clinical outcomes. This study aims to determine if a structured bundle of enhanced infection-control measures can effectively reduce hospital-acquired IRPA cases at a tertiary care hospital. A retrospective interrupted time series analysis was conducted over two consecutive twelve-month periods: (1) 2023 served as the baseline period; (2) 2024 as the enhanced intervention period. The interventions included weekly active surveillance, prompt notification to physicians after positive culture results, structured on-site audits with a standardized checklist for isolating multidrug-resistant organisms, and monthly departmental performance reports. A total of 850 clinical isolates were analyzed. The main outcomes measured were the overall IRPA incidence, hospital-acquired IRPA infection rates, adherence to contact precautions for IRPA patients, and total Imipenem use, each expressed as a rate per 1,000 patient-days. Segmented linear regression was used for the interrupted time series analysis. IRPA incidence decreased from 1.842 to 0.963 cases per 1,000 patient-days (p < 0.001), and hospital-acquired IRPA infection rates dropped from 0.214 to 0.088 per 1,000 patient-days (p = 0.001). Contact isolation compliance increased from 31.4% to 76.2% (p < 0.001). Imipenem use rose to 1.183 defined daily doses per 1,000 patient-days per quarter (p = 0.002), with no significant change in this trend due to the intervention (p = 0.112). The implementation of a structured infection control bundle focusing on weekly surveillance and real-time notification led to a significant clinical and statistical reduction in hospital-acquired IRPA, despite increased Imipenem use. These findings offer practical evidence for resource-limited tertiary care settings.

Zitieren

APA

Bhusal, C. K., & Rasheed, H. J. (2026). Controlling Imipenem-Resistant Pseudomonas aeruginosa in Hospitals: Effect of Improved Infection Control Measures from an Interrupted Time-Series Study. World Journal of Experimental Biosciences, 10-15. https://doi.org/10.65329/wjeb.v14.01.03

Vancouver

Bhusal CK, Rasheed HJ. Controlling Imipenem-Resistant Pseudomonas aeruginosa in Hospitals: Effect of Improved Infection Control Measures from an Interrupted Time-Series Study. World Journal of Experimental Biosciences. 2026:10-15. doi:10.65329/wjeb.v14.01.03

BibTeX
@article{Bhusal2026,
  author = {Bhusal, Chandra Kanta and Rasheed, Hanaa Jabbar},
  title = {Controlling Imipenem-Resistant Pseudomonas aeruginosa in Hospitals: Effect of Improved Infection Control Measures from an Interrupted Time-Series Study},
  journal = {World Journal of Experimental Biosciences},
  year = {2026},
  pages = {10--15},
  doi = {10.65329/wjeb.v14.01.03}
}
Kostenlos starten →